Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
Advertisement
Articles by Yvonne Efebera, MD, Ohio State University Comprehensive Cancer Center
Advertisement
Latest Updated Articles
Targeted Treatment Options in Multiple MyelomaAugust 10th 2020
The Future of Multiple MyelomaAugust 10th 2020
A Look at the ENDURANCE TrialAugust 10th 2020
Maintenance Therapy in Multiple MyelomaAugust 10th 2020
Treatment Options in Relapsed/Refractory Multiple MyelomaAugust 10th 2020
Trials in Relapsed/Refractory Multiple MyelomaAugust 10th 2020
Advertisement
Advertisement
Trending on OncLive
1
Petosemtamab Plus Pembrolizumab Hits Phase 3 OS, ORR Primary End Points in PD-L1+ R/M HNSCC
2
Breaking Down Key Lung Cancer Data at ESMO 2026 With Drs Santos and Halmos
3
FDA Receives BLA for Etentamig in R/R Multiple Myeloma
4
Sac-TMT Plus Pembrolizumab Improves PFS in PD-L1–Negative Nonsquamous NSCLC
5